EP3191461
Kristölluð fastefnisform af 6-karboxý-2-(3,5-díklórfenýl)-bensoxasól
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
31.8.2015EP published:
3.11.2021EP application number:
15771276.1
EP translation filed:
9.12.2021Grant published:
15.1.2022EPO information:
European Patent Register
Max expiry date:
30.8.2035Expiry date:
30.8.2026Next due date:
31.8.2026
Title in English:
CRYSTALLINE SOLID FORMS OF 6-CARBOXY-2-(3,5-DICHLOROPHENYL)-BENZOXAZOLELanguage of the patent:
English
Timeline
Today
31.8.2015EP application
3.11.2021EP Publication
9.12.2021Translation submitted
15.1.2022Registration published
30.8.2026Expires
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
GIRARD, Kevin PaulAddress:
Quaker Hill, Connecticut 06375, US
Name:
JENSEN, Andrew J.Address:
Ledyard, Connecticut 06339, US
Name:
JONES, Kris NicoleAddress:
Waterford, Connecticut 06385, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462047614 PDate:
8.9.2014Country:
US
Number:
201562203953 PDate:
12.8.2015Country:
US
Classification
Categories:
C07D 263/57, A61K 31/423, A61P 25/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 1.6.2022
Expires: 30.8.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 21.6.2023
Expires: 30.8.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 23.7.2024
Expires: 30.8.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.8.2025
Expires: 30.8.2026
Payer: Árnason Faktor ehf.